Literature DB >> 7538672

The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein.

I M Buyse1, G Shao, S Huang.   

Abstract

The retinoblastoma protein (Rb) is a target of viral oncoproteins. To explore the hypothesis that viral proteins may be structural mimics of cellular proteins, we have searched cDNA libraries for Rb-binding proteins. We report here the cloning of a cDNA for the protein RIZ from rat and human cells. RIZ is a 250-kDa nuclear protein containing eight zinc-finger motifs. It contains an Rb-binding motif that shares an antigenic epitope with the C terminus of E1A. A domain is conserved between RIZ and the PRDI-BF1/Blimp-1 differentiation factor. Other motifs of RIZ include putative GTPase and SH3 (src homology domain 3) domains. RIZ is preferentially expressed in both adult and embryonic rat neuroendocrine tissues. It is also expressed in human retinoblastoma cells and at low levels in all other human cell lines examined. While the function of RIZ is not yet clear, its structure and pattern of expression suggest a role for RIZ in transcriptional regulation during neuronal differentiation and pathogenesis of retinoblastoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538672      PMCID: PMC41965          DOI: 10.1073/pnas.92.10.4467

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

Review 1.  Zinc finger domains: hypotheses and current knowledge.

Authors:  J M Berg
Journal:  Annu Rev Biophys Biophys Chem       Date:  1990

Review 2.  The GTPase superfamily: conserved structure and molecular mechanism.

Authors:  H R Bourne; D A Sanders; F McCormick
Journal:  Nature       Date:  1991-01-10       Impact factor: 49.962

3.  A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle.

Authors:  P J Welch; J Y Wang
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

4.  Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells.

Authors:  C A Turner; D H Mack; M M Davis
Journal:  Cell       Date:  1994-04-22       Impact factor: 41.582

Review 5.  Integration of cell cycle control with transcriptional regulation by the retinoblastoma protein.

Authors:  R E Hollingsworth; P L Chen; W H Lee
Journal:  Curr Opin Cell Biol       Date:  1993-04       Impact factor: 8.382

6.  A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product.

Authors:  S Huang; W H Lee; E Y Lee
Journal:  Nature       Date:  1991-03-14       Impact factor: 49.962

7.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.

Authors:  N Dyson; P M Howley; K Münger; E Harlow
Journal:  Science       Date:  1989-02-17       Impact factor: 47.728

8.  Direct cloning of leucine zipper proteins: Jun binds cooperatively to the CRE with CRE-BP1.

Authors:  P F Macgregor; C Abate; T Curran
Journal:  Oncogene       Date:  1990-04       Impact factor: 9.867

9.  Physical interaction of the retinoblastoma protein with human D cyclins.

Authors:  S F Dowdy; P W Hinds; K Louie; S I Reed; A Arnold; R A Weinberg
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

Review 10.  Speculations on the roles of RB1 in tissue-specific differentiation, tumor initiation, and tumor progression.

Authors:  P A Hamel; R A Phillips; M Muncaster; B L Gallie
Journal:  FASEB J       Date:  1993-07       Impact factor: 5.191

View more
  53 in total

1.  Identification of a zinc finger protein whose subcellular distribution is regulated by serum and nerve growth factor.

Authors:  A Chittka; M V Chao
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

2.  Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.

Authors:  F A Dick; E Sailhamer; N J Dyson
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

Review 3.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

4.  Variety is the splice of life.

Authors:  Anne Hamik; Mukesh K Jain
Journal:  J Mol Cell Cardiol       Date:  2007-09-29       Impact factor: 5.000

5.  PRDM6 is enriched in vascular precursors during development and inhibits endothelial cell proliferation, survival, and differentiation.

Authors:  Yaxu Wu; James E Ferguson; Hong Wang; Rusty Kelley; Rongqin Ren; Holly McDonough; James Meeker; Peter C Charles; Hengbin Wang; Cam Patterson
Journal:  J Mol Cell Cardiol       Date:  2007-06-30       Impact factor: 5.000

6.  Structural and functional characterization of the acidic region from the RIZ tumor suppressor.

Authors:  Yizhi Sun; Jessica M Stine; Daniel Z Atwater; Ayesha Sharmin; J B Alexander Ross; Klára Briknarová
Journal:  Biochemistry       Date:  2015-02-02       Impact factor: 3.162

7.  Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.

Authors:  S Fears; C Mathieu; N Zeleznik-Le; S Huang; J D Rowley; G Nucifora
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

8.  Riz maps to distal chromosome 4 near genes involved in tumorigenesis and nerve degeneration.

Authors:  B A Mock; M P Coleman; S Huang
Journal:  Mamm Genome       Date:  1996-08       Impact factor: 2.957

9.  In vitro analysis of the E1A-homologous sequences of RIZ.

Authors:  I M Buyse; S Huang
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

10.  Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancer.

Authors:  H Matsumoto; H Matsuyama; K Fukunaga; S Yoshihiro; T Wada; K Naito
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.